Eisler Capital (UK)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$66.1M Buy
2,285,175
+668,841
+41% +$19.5M 0.31% 69
2024
Q2
$45.2M Buy
1,616,334
+494,762
+44% +$13.6M 0.29% 83
2024
Q1
$31.1M Buy
1,121,572
+320,543
+40% +$8.89M 0.26% 97
2023
Q4
$23.1M Buy
801,029
+517,733
+183% +$15.7M 0.18% 123
2023
Q3
$9.4M Buy
+283,296
New +$10M 0.06% 219

Other funds holding PFE

Eisler Capital (UK)'s PFE Position: Q3 2024 in Review

Eisler Capital (UK) increased its Pfizer (PFE) stake by 25% in Q3 2024, buying an estimated $164K and bringing the position to 27,854 shares worth $806K. The position accounts for ﹤0.01% of the portfolio, ranked #504.

Eisler Capital (UK) first reported a position in PFE in Q3 2023 and has held it in 5 quarters since. The position peaked at $3.5M in Q4 2023. 2,910 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Eisler Capital (UK) held 27,854 shares of Pfizer worth $806K as of Q3 2024.
  • Eisler Capital (UK) bought 5,629 Pfizer shares in Q3 2024, an estimated $164K.
  • Pfizer made up ﹤0.01% of Eisler Capital (UK)'s portfolio in Q3 2024, its #504 holding.
  • Eisler Capital (UK) first reported a position in Pfizer in Q3 2023 and has held it in 5 quarters since.
  • Eisler Capital (UK)'s Pfizer position peaked at $3.5M in Q4 2023.
  • 2,910 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Eisler Capital (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.